- Home
- GT vs CRVS Comparison
GT vs CRVS Comparison
Compare GT & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GT | CRVS |
|---|---|---|
| Founded | 1898 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GT | CRVS |
|---|---|---|
| Price | $7.11 | $16.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $10.56 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 8.0M | 1.1M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,280,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.38 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.51 | $2.54 |
| 52 Week High | $12.03 | $26.95 |
Technical Indicators
Market Signals| Indicator | GT | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 24.58 | 47.33 |
| Support Level | $6.64 | $16.15 |
| Resistance Level | $7.33 | $18.73 |
| Average True Range (ATR) | 0.28 | 0.97 |
| MACD | -0.16 | -0.41 |
| Stochastic Oscillator | 4.37 | 40.99 |
Price Performance
Historical ComparisonAbout GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).